Literature DB >> 6159006

Identification of proteinases in rheumatoid synovium. Detection of leukocyte elastase cathepsin G and another serine proteinase.

J Saklatvala, A J Barrett.   

Abstract

Extracts of rheumatoid synovial tissue obtained at surgical synovectomy contained neutral proteinases as well as cathepsin D. The neutral proteinase activity was particle-bound but could be solubilized by 1 M MgCl2. About half of the solubilized activity adsorbed to aproptinin-Sepharose at pH 7.5 and was desorbed at pH 3.3. This activity was shown to be due to leukocyte elastase and cathepsin G by enzymological and immunological criteria. The neutral proteinase activity that did not adsorb to aprotinin-Sepharose was not due to elastase or cathepsin G. It was able to hydrolyse proteoglycan and was inhibited by diisopropylfluorophosphate, soybean and lima bean trypsin inhibitors. It was, therefore, a serine proteinase. Its inhibition characteristics were different from those of plasmin, kallikrein or thrombin. All of the neutral proteinase activity of synovial extracts was attributable to serine proteinases, no evidence of metallo-proteinases was found. The possible role of the neutral proteinases in the degradation of the matrix of cartilage is discussed. A simple procedure for purifying leukocyte elastase and cathepsin G is described as well as the raising of specific antisera to these enzymes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159006     DOI: 10.1016/0005-2744(80)90020-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.

Authors:  J Elmgreen; O H Nielsen; I Ahnfelt-Rønne
Journal:  Ann Rheum Dis       Date:  1987-07       Impact factor: 19.103

2.  Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids.

Authors:  N Ahmadzadeh; M Shingu; M Nobunaga; T Tawara
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

3.  Factors influencing the acid-base changes in the air-pouch exudate following carrageenan induced inflammation in rats.

Authors:  V Alfaro; J Ródenas; J Pesquero; M T Mitjavila; L Palacios; T Carbonell
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

4.  Immunohistochemical demonstration of leucocyte elastase in human tissues.

Authors:  J Crocker; R Jenkins; D Burnett
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

5.  Isolation and characterization of a trypsin-like serine proteinase from the membranes of Walker 256 carcino-sarcoma cells.

Authors:  V J LaBombardi; E Shaw; J F DiStefano; G Beck; F Brown; S Zucker
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

6.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

7.  Cystatin-like cysteine proteinase inhibitors from human liver.

Authors:  G D Green; A A Kembhavi; M E Davies; A J Barrett
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

8.  Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents.

Authors:  E C LeRoy; A Ager; J L Gordon
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Human mononuclear cells and neutral proteinases. III. Neutral proteinases and rheumatoid arthritis: monocytes as a source of cathepsin G and proteinase potentiation of IgM rheumatoid factor elaboration.

Authors:  R S Panush
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

10.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.